PMID- 17040976 OWN - NLM STAT- MEDLINE DCOM- 20070320 LR - 20200930 IS - 0363-6135 (Print) IS - 0363-6135 (Linking) VI - 292 IP - 2 DP - 2007 Feb TI - Peroxynitrite diminishes myogenic tone in cerebral arteries: role of nitrotyrosine and F-actin. PG - H1042-50 AB - This study investigated the effect of peroxynitrite (OONO(-))-induced nitrosylation of filamentous (F)-actin on myogenic tone in isolated and pressurized posterior cerebral arteries (PCAs). Immunohistochemical staining was used to determine 3-nitrotyrosine (NT) and F-actin content in vascular smooth muscle after exposure to 10(-7) M or 10(-4) M OONO(-) for 5 or 60 min in isolated third-order PCAs (n = 37) from male Wistar rats pressurized to 75 mmHg in an arteriograph chamber, quantified with confocal microscopy. Additionally, the role of K(+) channels in OONO(-)-induced dilation was investigated with 3 microM glibenclamide or 10 mM tetraethylammonium chloride before OONO(-) exposure. OONO(-) (10(-4) M) induced a 40% dilation of tone (P < 0.05) while diminishing F-actin content by half (P < 0.05) and causing a 60-fold increase in NT (P < 0.05) in the vascular smooth muscle of PCAs. Additionally, F-actin was inversely correlated with both diameter and NT content (P < 0.05) and was significantly colocalized in the vascular smooth muscle with NT (overlap coefficient = 0.8). The dilation to ONOO(-) was independent of K(+) channel activity and thiol oxidation as glibenclamide, tetraethylammonium chloride, and dithiothreitol had no effect on OONO(-)-induced dilation or F-actin or NT content in PCAs. Because NT was colocalized with F-actin, we hypothesize that OONO(-) induces nitrosylation of F-actin in vascular smooth muscle leading to depolymerization and the subsequent loss of myogenic tone, which may promote vascular damage during oxidative stress such as in ischemia and reperfusion injury. FAU - Maneen, Matthew J AU - Maneen MJ AD - Department of Neurology, University of Vermont, 89 Beaumont Ave., Given C454, Burlington, VT 05405, USA. FAU - Cipolla, Marilyn J AU - Cipolla MJ LA - eng GR - R01 NS043316/NS/NINDS NIH HHS/United States GR - R01 NS040071/NS/NINDS NIH HHS/United States GR - R01-NS-045940/NS/NINDS NIH HHS/United States GR - R01-NS-040071/NS/NINDS NIH HHS/United States GR - R01-NS-043316/NS/NINDS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20061013 PL - United States TA - Am J Physiol Heart Circ Physiol JT - American journal of physiology. Heart and circulatory physiology JID - 100901228 RN - 0 (Actins) RN - 0 (Potassium Channel Blockers) RN - 0 (Potassium Channels) RN - 0 (Sulfhydryl Compounds) RN - 14691-52-2 (Peroxynitrous Acid) RN - 3604-79-3 (3-nitrotyrosine) RN - 42HK56048U (Tyrosine) RN - 66-40-0 (Tetraethylammonium) RN - SX6K58TVWC (Glyburide) RN - T8ID5YZU6Y (Dithiothreitol) SB - IM MH - Actins/*metabolism MH - Animals MH - Dithiothreitol/pharmacology MH - Dose-Response Relationship, Drug MH - Glyburide/pharmacology MH - Immunohistochemistry MH - In Vitro Techniques MH - Male MH - Microscopy, Confocal MH - Oxidation-Reduction MH - Peroxynitrous Acid/*metabolism/pharmacology MH - Posterior Cerebral Artery/drug effects/*metabolism MH - Potassium Channel Blockers/pharmacology MH - Potassium Channels/drug effects/metabolism MH - Rats MH - Rats, Wistar MH - Sulfhydryl Compounds/metabolism MH - Tetraethylammonium/pharmacology MH - Time Factors MH - Tyrosine/*analogs & derivatives/metabolism MH - *Vasodilation/drug effects EDAT- 2006/10/17 09:00 MHDA- 2007/03/21 09:00 CRDT- 2006/10/17 09:00 PHST- 2006/10/17 09:00 [pubmed] PHST- 2007/03/21 09:00 [medline] PHST- 2006/10/17 09:00 [entrez] AID - 00800.2006 [pii] AID - 10.1152/ajpheart.00800.2006 [doi] PST - ppublish SO - Am J Physiol Heart Circ Physiol. 2007 Feb;292(2):H1042-50. doi: 10.1152/ajpheart.00800.2006. Epub 2006 Oct 13.